GHK-Cu acts through three main pathways: epigenetic modulation (4,000+ genes, 31.2% of the genome), stimulation of collagen/elastin/GAG synthesis, and copper transport for the activation of antioxidant SOD and wound-healing enzymes
("YHI") to explore a California expansion, but the parties could not agree on terms
Ozempic, Wegovy and Mounjaro are all administered on a weekly basis through a subcutaneous injection, with the outlier being Mounjaro due to the significantly higher starting dosage (2.5mg compared to 0.5mg for the other two)
Some users experiment with twice-daily dosing or cycling protocols, but these approaches lack scientific support and may increase the risk of adverse effects
Further reading: Retatrutide results These results are impressive, but they are not from a direct head-to-head trial